You are here

  • Home
  • Archive
  • Volume 71, Issue 2
  • Predicting low disease activity and remission using early treatment response to antitumour necrosis factor therapy in patients with rheumatoid arthritis: exploratory analyses from the TEMPO trial

Citation Tools

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
Predicting low disease activity and remission using early treatment response to antitumour necrosis factor therapy in patients with rheumatoid arthritis: exploratory analyses from the TEMPO trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Curtis JR, Yang S, Chen L, et al
Predicting low disease activity and remission using early treatment response to antitumour necrosis factor therapy in patients with rheumatoid arthritis: exploratory analyses from the TEMPO trial
Annals of the Rheumatic Diseases 2012;71:206-212.